Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

IL-18 signaling helps mature Tregs move into the thymus.

Lung immune cells can be trained to better fight infections after a virus.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Antibodies help identify glycoproteins in normal skin and tumor cells.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

CT60 polymorphism might increase the risk of Alopecia Areata.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Th22 cells are essential for Tβ15-induced hair growth in mice.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

The Fas/FasL pathway may play a role in alopecia areata.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Alopecia areata may be linked to higher heart disease risk.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.